This review explores how nanotechnology, particularly magnetic nanoparticles (MNPs), enhances drug solubility, bioavailability, and targeted therapeutic applications. Biological variability poses significant challenges in drug development, as it affects drug solubility and bioavailability, leading to inconsistent therapeutic outcomes. MNPs offer innovative solutions by improving drug solubility and enabling targeted delivery. The review highlights recent advancements in nanotechnology, emphasizing the role of continued innovation in addressing biological variability. Future research should focus on developing universal therapeutic solutions, interdisciplinary research, and personalized nanomedicine. MNPs can be engineered to penetrate biological membranes, deliver drugs in a controlled manner, and improve bioavailability. They are particularly effective in targeted drug delivery, where they can be guided to specific sites in the body, such as tumors, using external magnetic fields. MNPs also enhance drug solubility by improving drug loading and solubility through surface modifications. The review discusses various case studies where MNPs have improved drug solubility and bioavailability, such as in the treatment of colorectal cancer, where curcumin-loaded MNPs enhanced bioavailability. MNPs are also used in targeted delivery within the gastrointestinal tract, where they can navigate the complex environment and improve drug absorption. The review concludes that nanotechnology, particularly MNPs, holds great promise in enhancing drug delivery and efficacy, offering a personalized approach to medicine. The integration of MNPs with other technologies, such as imaging and hyperthermia, further enhances their therapeutic potential. The review emphasizes the importance of continued research in this field to develop more effective and targeted therapeutic strategies.This review explores how nanotechnology, particularly magnetic nanoparticles (MNPs), enhances drug solubility, bioavailability, and targeted therapeutic applications. Biological variability poses significant challenges in drug development, as it affects drug solubility and bioavailability, leading to inconsistent therapeutic outcomes. MNPs offer innovative solutions by improving drug solubility and enabling targeted delivery. The review highlights recent advancements in nanotechnology, emphasizing the role of continued innovation in addressing biological variability. Future research should focus on developing universal therapeutic solutions, interdisciplinary research, and personalized nanomedicine. MNPs can be engineered to penetrate biological membranes, deliver drugs in a controlled manner, and improve bioavailability. They are particularly effective in targeted drug delivery, where they can be guided to specific sites in the body, such as tumors, using external magnetic fields. MNPs also enhance drug solubility by improving drug loading and solubility through surface modifications. The review discusses various case studies where MNPs have improved drug solubility and bioavailability, such as in the treatment of colorectal cancer, where curcumin-loaded MNPs enhanced bioavailability. MNPs are also used in targeted delivery within the gastrointestinal tract, where they can navigate the complex environment and improve drug absorption. The review concludes that nanotechnology, particularly MNPs, holds great promise in enhancing drug delivery and efficacy, offering a personalized approach to medicine. The integration of MNPs with other technologies, such as imaging and hyperthermia, further enhances their therapeutic potential. The review emphasizes the importance of continued research in this field to develop more effective and targeted therapeutic strategies.